Agenus Inc (AGEN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Garo H. Armen
Employees:
440
3 FORBES ROAD, LEXINGTON, MA 02421
781-674-4410

Agenus Inc. discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It also develops Balstilimab, an anti-PD-1 antagonist that has completed Phase II clinical trial to treat second line cervical cancer.

Data derived from most recent annual or quarterly report
Market Cap 783.366 Million Shares Outstanding304.812 Million Avg 30-day Volume 4.329 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.64
Price to Revenue6.5411 Debt to Equity-6.5288 EBITDA-168.986 Million
Price to Book Value0.0 Operating Margin-195.435 Enterprise Value455.645 Million
Current Ratio1.453 EPS Growth-6.4 Quick Ratio1.312
1 Yr BETA 1.8084 52-week High/Low 3.37 / 1.25 Profit Margin-249.3421
Operating Cash Flow Growth-5895.3137 Altman Z-Score-5.4703 Free Cash Flow to Firm -182.845 Million
Earnings Report2023-02-28
View SEC Filings from AGEN instead.

View recent insider trading info

Funds Holding AGEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AGEN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-12-23:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-12-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 3.02: Unregistered Sales of Equity Securities
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-05:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-25:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-01:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-01-06:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2021-11-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    WIINBERG ULF

    • Director
    100,000 2023-01-08 5

    HIRSCH SUSAN B

    • Director
    100,000 2023-01-08 4

    ARMEN GARO H CHAIRMAN AND CEO

    • Officer
    • Director
    4,354,136 2023-01-05 1

    KLASKIN CHRISTINE M PFO & PAO

    • Officer
    316,853 2023-01-05 1

    O'DAY STEVEN J CHIEF MEDICAL OFFICER

    • Officer
    472,384 2023-01-05 1

    WRIGHT TIMOTHY

    • Director
    150,597 2023-01-03 4

    JORDAN WADIH

    • Director
    239,945 2022-10-03 3

    CORVESE BRIAN

    • Director
    150,000 2022-02-04 0

    JEYNES-ELLIS ALLISON M

    • Director
    100,000 2022-02-04 0

    BUELL JENNIFER COO AND PRESIDENT

    • Officer
    1,027,091 2021-06-15 0

    KRAUSS ADAM CHIEF LEGAL OFFICER

    • Officer
    175,000 2021-06-15 0

    CLARK PAUL N

    • Director
    5,093 2021-04-01 0

    KEARNS EVAN VP AND GENERAL COUNSEL

    • Officer
    0 2020-12-17 0

    INCYTE CORP

    • 10% Owner
    No longer subject to file 2020-06-16 0

    DUNCAN ALEX CHIEF TECHNOLOGY OFFICER

    • Officer
    0 2019-07-23 0

    CORTIS CHRISTIAN CHIEF STRATEGY OFFICER

    • Officer
    0 2019-07-23 0

    VALENTINE KAREN CHIEF LEGAL OFFICER AND GC

    • Officer
    0 2018-06-20 0

    BAYSAL OZER CHIEF COMMERCIAL OFFICER

    • Officer
    0 2018-06-20 0

    SHARP SHALINI

    • Director
    0 2018-03-02 0

    STEIN ROBERT BENJAMIN PRESIDENT R&D

    • Officer
    No longer subject to file 2017-03-31 0

    CUILLEROT JEAN-MARIE CHIEF MEDICAL OFFICER

    • Officer
    0 2017-03-31 0

    MALIK SHAHZAD

    • Director
    0 2016-06-15 0

    BALLANTYNE CHARLES EVAN CFO

    • Officer
    0 2016-06-14 0

    DECHAENE TOM

    • Director
    No longer subject to file 2016-01-04 0

    QVT ASSOCIATES GP LLC

    QVT FUND V LP

    • 10% Owner
    No longer subject to file 2015-01-09 0

    WENTWORTH KERRY VP, CLINICAL, REG & QUAL

    • Officer
    57,410 2014-02-26 0

    ROTHWELL TIMOTHY G

    • Director
    No longer subject to file 2011-12-08 0

    HATSOPOULOS JOHN

    • Director
    No longer subject to file 2011-12-08 0

    LEVITSKY HYAM

    • Director
    No longer subject to file 2011-08-28 0

    MARGARET EISEN

    • Director
    No longer subject to file 2009-06-11 0

    THORNTON PETER

    • Director
    0 2008-06-05 0

    INVUS PUBLIC EQUITIES, LP

    INVUS PUBLIC EQUITIES ADVISORS, LLC

    ULYS, LLC

    DEBBANE RAYMOND

    • 10% Owner
    3,533,333 2008-05-10 0

    ATLEE FRANK V III

    • Director
    114,117 2007-04-02 0

    AFEYAN NOUBAR

    • Director
    255,275 2007-04-02 0

    CHICZ ROMAN SVP, RESEARCH AND DEVELOPMENT

    • Officer
    28,500 2007-01-05 0

    LEICHER BRUCE VP, GENERAL COUNSEL

    • Officer
    0 2006-12-15 0

    KESSEL MARK

    • Director
    85,630 2006-10-02 0

    WOOD ALASTAIR JJ

    • Director
    0 2006-09-14 0

    GUPTA RENU SR. VP DEVELOPMENT

    • Officer
    0 2006-07-20 0

    CHADAREVIAN GAMIL DE

    • Director
    1,701,290 2006-02-28 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    WIINBERG ULF - Director

    2023-01-09 19:02:27 -0500 2023-01-08 A 100,000 a 100,000 direct

    JEYNES-ELLIS ALLISON M - Director

    2023-01-09 19:05:01 -0500 2023-01-08 A 100,000 a 100,000 direct

    WRIGHT TIMOTHY - Director

    2023-01-09 19:07:15 -0500 2023-01-08 A 150,000 a 150,000 direct

    HIRSCH SUSAN B - Director

    2023-01-09 19:14:28 -0500 2023-01-08 A 100,000 a 100,000 direct

    O'DAY STEVEN J - Officer CHIEF MEDICAL OFFICER

    2023-01-09 17:42:48 -0500 2023-01-05 A 109,381 $2.45 a 272,384 direct 0.0 2.2727 11.7424 4 0.0 1

    O'DAY STEVEN J - Officer CHIEF MEDICAL OFFICER

    2023-01-09 17:42:48 -0500 2023-01-05 A 200,000 a 200,000 direct

    KLASKIN CHRISTINE M - Officer PFO & PAO

    2023-01-09 17:48:34 -0500 2023-01-05 A 31,294 $2.45 a 153,937 direct 0.0 2.2727 11.7424 4 0.0 1

    KLASKIN CHRISTINE M - Officer PFO & PAO

    2023-01-09 17:48:34 -0500 2023-01-05 A 162,916 a 162,916 direct

    ARMEN GARO H - Director - Officer CHAIRMAN AND CEO

    2023-01-09 18:03:11 -0500 2023-01-05 A 241,383 $2.45 a 1,249,167 direct 0.0 2.2727 11.7424 4 0.0 1

    ARMEN GARO H - Director - Officer CHAIRMAN AND CEO

    2023-01-09 18:03:11 -0500 2023-01-05 A 2,400,000 a 2,400,000 direct

    WRIGHT TIMOTHY - Director

    2023-01-04 11:15:50 -0500 2023-01-03 A 3,620 a 150,597 direct

    HIRSCH SUSAN B - Director

    2023-01-04 11:20:43 -0500 2023-01-03 A 7,239 $2.59 a 108,725 direct -2.7778 4.7619 4.7619 5 -5.9524 4

    WIINBERG ULF - Director

    2023-01-04 11:25:35 -0500 2023-01-03 A 9,894 a 163,608 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    AGENUS INC AGEN 2023-02-03 22:15:03 UTC 4.2934 0.2766 4300000
    AGENUS INC AGEN 2023-02-03 21:45:03 UTC 4.293 0.277 4300000
    AGENUS INC AGEN 2023-02-03 21:15:03 UTC 4.293 0.277 4300000
    AGENUS INC AGEN 2023-02-03 20:45:06 UTC 4.293 0.277 4300000
    AGENUS INC AGEN 2023-02-03 20:15:04 UTC 4.293 0.277 4300000
    AGENUS INC AGEN 2023-02-03 19:45:03 UTC 4.293 0.277 4200000
    AGENUS INC AGEN 2023-02-03 19:15:04 UTC 4.293 0.277 4200000
    AGENUS INC AGEN 2023-02-03 18:45:03 UTC 4.293 0.277 4200000
    AGENUS INC AGEN 2023-02-03 18:15:03 UTC 4.293 0.277 4200000
    AGENUS INC AGEN 2023-02-03 17:45:03 UTC 4.293 0.277 4200000
    AGENUS INC AGEN 2023-02-03 17:15:04 UTC 4.293 0.277 4200000
    AGENUS INC AGEN 2023-02-03 16:45:04 UTC 4.293 0.277 4200000
    AGENUS INC AGEN 2023-02-03 16:15:03 UTC 4.293 0.277 4200000
    AGENUS INC AGEN 2023-02-03 15:45:03 UTC 4.293 0.277 4300000
    AGENUS INC AGEN 2023-02-03 15:15:03 UTC 4.293 0.277 4300000
    AGENUS INC AGEN 2023-02-03 14:45:04 UTC 4.0578 0.2622 4300000
    AGENUS INC AGEN 2023-02-03 14:15:04 UTC 4.0578 0.2622 4300000
    AGENUS INC AGEN 2023-02-03 13:45:03 UTC 4.0578 0.2622 4300000
    AGENUS INC AGEN 2023-02-03 13:15:03 UTC 4.0578 0.2622 4300000
    AGENUS INC AGEN 2023-02-03 12:45:03 UTC 4.0578 0.2622 4300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund AGEN -4800.0 shares, $-9840.0 2022-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments